Bibliographic citations
Escobedo, A., (2022). Resultados maternos y neonatales en gestantes con preeclampsia infectadas por COVID-19 [Tesis, Universidad Privada Antenor Orrego. Escuela de Postgrado]. https://hdl.handle.net/20.500.12759/9419
Escobedo, A., Resultados maternos y neonatales en gestantes con preeclampsia infectadas por COVID-19 [Tesis]. PE: Universidad Privada Antenor Orrego. Escuela de Postgrado; 2022. https://hdl.handle.net/20.500.12759/9419
@mastersthesis{renati/379984,
title = "Resultados maternos y neonatales en gestantes con preeclampsia infectadas por COVID-19",
author = "Escobedo Medina, Adela Margot",
publisher = "Universidad Privada Antenor Orrego. Escuela de Postgrado",
year = "2022"
}
To determine whether in pregnant women with preeclampsia, SARS-CoV-2 infection increases the risk of a higher incidence of maternal and neonatal complications compared to those without SARS-CoV-2 infection. MATERIAL AND METHODS: A population-based cohort study was performed, in pregnant women with preeclampsia during the years 2020 and 2021, with and without COVID-19 diagnosis confirmed by antigenic or molecular methods; the preeclampsia group with COVID-19 were 79 pregnant women and the preeclampsia group without COVID-19 were 79 pregnant women. RESULTS: Mean age in pregnant women with preeclampsia with and without COVID-19 were 29.24 ± 6.66 and 28.10 ± 7.25 (p = 0.305); maternal outcomes in pregnant women with preeclampsia with and without COVID-19 such as gestational age (35.91 ± 3.90 and 37.09 ± 2.68; p = 0.028) and type of cesarean delivery (65.82% and 41.77%, p = 0.028) were found to be associated with COVID-19. Perinatal death (13.92% vs 3.80%, p = 0.025) was associated with the presence of COVID-19. CONCLUSIONS: The presence of COVID-19 in pregnant women with preeclampsia does increase maternal and perinatal complications.
This item is licensed under a Creative Commons License